At COVID's current high case rate (as of 15 September 2021) of 680/100,000 population/week in 10-19-year-olds in England, researchers have found that the benefits associated with two doses of the Pfizer vaccine in terms of reducing hospital admissions outweigh the risks associated with the vaccine. Benefit of vaccination exists at any case rate for the outcomes of death and long COVID, since neither have been associated with vaccination to date.
Media Coverage:
UCL Queen Square Institute of Neurology achieves Gold in UCL Sustainability awards 2025
We're delighted to announce recognition of UCL Queen Square Institute of Neurology's commitment to sustainability at UCL’s Awards ceremony, taking home all Gold awards.
09 Jul 2025
Change the PATTERN: Addressing Unacceptable Behaviours in Academia
The PATTERN campaign is a collaborative initiative by UCL Queen Square Institute of Neurology and Koç University
08 Jul 2025
Global Business School for Health on the NHS 10 Year Plan for England
Professor Nora Colton, Director of the Global Business School for Health, responds to the recently published NHS 10 Year Plan for England
08 Jul 2025